INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 12th, 2020 • Sensei Biotherapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of January 10, 2020, by and among Sensei Biotherapeutics, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • November 12th, 2020 • Sensei Biotherapeutics, Inc. • Pharmaceutical preparations • Washington
THIS NON-EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made and effective as of January 3, 2020 (the “Effective Date”) by and between Alvaxa Biosciences, Incorporated having a principal place of business at 2126 N. 51st Street, Seattle, WA 98103 (“Company”), and Fred Hutchinson Cancer Research Center (“Fred Hutch”), having a principal place of business at 1100 Fairview Avenue North, Seattle Washington 98109-1024, USA.
